Ignite Creation Date:
2025-12-24 @ 7:16 PM
Ignite Modification Date:
2025-12-30 @ 7:21 AM
Study NCT ID:
NCT00224003
Status:
COMPLETED
Last Update Posted:
2009-09-28
First Post:
2005-09-13
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Study of the Safety and Efficacy of Ferrlecit® Maintenance Dosing in Pediatric Hemodialysis Patients
Sponsor:
Watson Pharmaceuticals
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
FRO2001
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
None
Responsible Party Affiliation:
Old Name:
Gary Hoel, RPh, PhD Executive Director, Clinical Research
Old Organization:
Watson Laboratory, Inc